Zentalis Pharmaceuticals ZNTL
NASDAQ ZNTL
$1.89 +0.09 (+5.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Zentalis Pharmaceuticals (ZNTL) Asset Writedowns and Impairment (2023 - 2025)

Updated

Zentalis Pharmaceuticals (ZNTL) reported Asset Writedowns and Impairment of $2.98 million for Q4 2025, down 19.4% from $3.7 million a year earlier.

Analysis

Zentalis Pharmaceuticals (ZNTL) Asset Writedowns and Impairment (2023 - 2025) Analysis & Trends

For FY2025, Zentalis Pharmaceuticals posted Asset Writedowns and Impairment of $4.14 million, up 10.7% from FY2024.

  • Asset Writedowns and Impairment has a four-year compound annual growth rate of -17.2% (FY2021 to FY2025).
  • By year, Asset Writedowns and Impairment came in at $3.74 million in FY2024 (-24.6%), $4.95 million in FY2023 and $8.8 million in FY2021.
  • Five-year quarterly Asset Writedowns and Impairment spans a low of $1.15 million in Q1 2025 and a high of $4.95 million in Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Zentalis Pharmaceuticals 176.87 Mn -684.28 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2.98 Mn
Mar 31, 2025 1.15 Mn
Dec 31, 2024 3.70 Mn
Mar 31, 2023 4.95 Mn
API Access

Zentalis Pharmaceuticals Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=ZNTL&period=max&api_key=YOUR_API_KEY